Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Dec. 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune,...

Hence then, the article about innovent announces publication of mazdutide ibi362 phase 2 full results in chinese patients with overweight or obesity in nature communications was published today ( Monday 18/12/2023 - 03:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications )

Also on site :

• The Nord Stream narrative explosion: Why you’ve only read half the story
• This 'Lightweight and Hydrating' Moisturizer Is a Frequent Repurchase for Ulta Shoppers—and It's Just $16
• Meet ERNEST, NASA’s Next-Generation Rover Designed to Be Faster and Tougher